Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)
Trial details
- Registry ID
- NCT02618408
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)NCT02618408 | SUPN | Phase 3 | Completed | 2019-09-04Actual |
| Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)NCT02618434 | SUPN | Phase 3 | Completed | 2019-11-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |